Evaluation of Hepatitis B and C Reactivation in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors. Mediterr J Hematol Infect Dis [Internet]. 2026 Jan. 1 [cited 2026 May 29];18(1):e2026001. Available from: https://www.mjhid.org/mjhid/article/view/5860